The prevalence of precautionary labelling remains high. This prevalence restricts food choices, in some cases perhaps unnecessarily, for food allergic consumers. During processing, cross-contamination does often occur in food products due to the way that modern processing facilities operate; however, zero risk of cross contamination is not a realistic expectation. There is evidence to suggest that threshold levels below which reactions are not provoked in allergic individuals do exist and these have been established in the literature for peanuts. Additional information such as understanding threshold levels will be important to this field of research. The data that will be obtained from future clinical trials will help to underpin action plans for precautionary labelling. This paper will review the current literature that is available regarding: consumer behaviour and attitudes regarding precautionary labelling; risk to the consumer and analytical results of products that bear advisory labelling; the current debate regarding whether a tolerable level of risk can be obtained in food allergy; and finally, the newly introduced Voluntary Incidental Trace Allergen Labelling (VITAL) system operating in Australia.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Papers of particular interest, published recently, have been highilghted as: •• Of major importance
Hefle SL, Furlong TJ, Niemann L, Lemon-Mule H, Sicherer S, Taylor SL. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts. Journal of Allergy and Clinical Immunology. 2007;120(1):171–6.
Osborne NJ, Koplin JJ, Martin PE, Gurrin LC, Lowe AJ, Matheson MC, et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. Journal of Allergy and Clinical Immunology. 2011;127(3):668–76.e2.
Prescott S, Allen KJ. Food allergy: Riding the second wave of the allergy epidemic. Pediatric Allergy and Immunology. 2011;22(2):155–60.
FSANZ. The Australian New Zealand Food Standards Code http://www.foodstandards.gov.au/foodstandardscode/ 2002.
EU. European Commission. Directive 2003/89/EC of the European Parliament and of the Council of 10 November 2003 amending Directive 2000/13/EC as regards induction of the ingredients present in foodstuffs. Official journal of the European communities. 2003;L308:15–8.
Congress US. Food Allergen Labeling and Consumer Protection Act of 2004 http://www.cfsan.fda.gov/~dms/alrgact.html. 2004.
Boden M, Dadswell R, Hattersley S. Review of statutory and voluntary labelling of food allergens. Proceedings of the Nutrition Society. 2005;64(04):475–80.
Zurzolo G, Mathai M, Koplin J, Allen K. Precautionary allergen labelling following new labelling practice in Australia, In press. Journal of Paediatrics and Child Health. 2012.
Koplin J, Osborne J, Allen J. Prevalence of allergen avoidance advisory statements on packaged processed foods in a supermarket. The Medical Journal of Australia. 2010;193(7).
Pele M, Brohée M, Anklam E, Hengel AJV. Peanut and hazelnut traces in cookies and chocolates: Relationship between analytical results and declaration of food allergens on product labels. Food Additives and Contaminants. 2007;24(12):1334–44.
Pieretti MM, Chung D, Pacenza R, Slotkin T, Sicherer SH. Audit of manufactured products: Use of allergen advisory labels and identification of labeling ambiguities. Journal of Allergy and Clinical Immunology. 2009;124(2):337–41.
Taylor SL, Hefle SL. Food allergen labeling in the USA and Europe. Current Opinion in Allergy and Clinical Immunology. 2006;6(3):186–90 10.1097/01.all.0000225158.75521.ad.
Connors M, Bisogni CA, Sobal J, Devine CM. Managing values in personal food systems. Appetite. 2001;36(3):189–200.
Noimark L, Gardner J, Warner JO. Parents’ attitudes when purchasing products for children with nut allergy: A UK perspective. Pediatric Allergy and Immunology. 2009;20(5):500–4.
Cornelisse-Vermaat JR, Voordouw J, Yiakoumaki V, Theodoridis G, Frewer LJ. Food-allergic consumers’ labelling preferences: a cross-cultural comparison. The European Journal of Public Health. 2008;18(2):115–20.
Taylor S, Baumert J. Cross-Contamination of Foods and Implications for Food Allergic Patients. Current Allergy and Asthma Reports. 2010;10(4):265–70.
Crotty MP, Taylor SL. Risks associated with foods having advisory milk labeling. Journal of Allergy and Clinical Immunology. 2010;125(4):935–7.
Ford LS, Taylor SL, Pacenza R, Niemann LM, Lambrecht DM, Sicherer SH. Food allergen advisory labeling and product contamination with egg, milk, and peanut. Journal of Allergy and Clinical Immunology. 2010;126(2):384–5.
Taylor SL, Hefle SL, Bindslev-Jensen C, Bock SA, Burks Jr AW, Christie L, et al. Factors affecting the determination of threshold doses for allergenic foods: How much is too much? Journal of Allergy and Clinical Immunology. 2002;109(1):24–30.
Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001–2006. Journal of Allergy and Clinical Immunology. 2007;119(4):1016–8.
•• Taylor SL, Crevel RWR, Sheffield D, Kabourek J, Baumert J. Threshold dose for peanut: Risk characterization based upon published results from challenges of peanut-allergic individuals. Food and Chemical Toxicology. 2009;47(6):1198–204. This article provides information on individual threshold doses.
•• Madsen CB, Hattersley S, Allen KJ, Beyer K, Chan CH, Godefroy SB, et al. Can we define a tolerable level of risk in food allergy? Report from a EuroPrevall/UK Food Standards Agency workshop. Clinical & Experimental Allergy. 2011:n/a-n/a. This article describes the current opinion from key stakeholders (regulators, food industry, clinical researchers and patients) regarding the definition of a tolerable level of risk
•• Allergen B. VITAL Q & A for Consumers. 2009; Available from: www.allergenbureau.net. This webpage provies details about the VITAL process.
Giovanni Zurzolo is a PhD scholar and is funded by Victoria University. Katrina J. Allen is an Associate Professor with the University of Melbourne and a Charles and Sylvia Viertel Senior Medical Research Fellow. Michael Mathai is an Associate Professor at the School of Biomedical and Health Sciences, Victoria University. Jennifer Koplin is supported by a NHMRC Capacity Building Grant in Population Health Postdoctoral Fellowship. The Murdoch Children's Research Institute is supported by funding from the Victorian Government's Operational Infrastructure Support Program.
Dr. Allen has received speakers’ fees from Abbott Laboratories, Pfizer and Danone/Nutricia.
Drs. Zurzolo, Mathai, and Koplin reported no potential conflicts of interest relevant to this article.
About this article
Cite this article
Zurzolo, G.A., Mathai, M.L., Koplin, J.J. et al. Hidden Allergens in Foods and Implications for Labelling and Clinical Care of Food Allergic Patients. Curr Allergy Asthma Rep 12, 292–296 (2012). https://doi.org/10.1007/s11882-012-0263-6
- Food allergy
- Precautionary labelling
- Voluntary Incidental Trace Allergen Labelling (VITAL)
- Eliciting dose (ED)
- One dose clinical trial
- Food allergic